Big Pharma’s Interest in IPF Drugs is a “360 Degree” Change, Pacific Therapeutics CEO Says
The chief executive officer and president of Pacific Therapeutics, a clinical stage specialty pharmaceutical company dedicated to the development of treatments for fibrosis and erectile dysfunction, commented on the recent interest of big pharmaceutical companies in acquiring therapies for the treatment of fibrosis. Doug Unwin said that…